PDCD1 and melanoma: It has been reported that the frequency of peripheral TCM was high after anti-PD-1 therapy in responders with melanoma, and the tumor-infiltrating TCM correlated with a favorable response to anti-PD-1 therapy in patients with Merkel cell carcinoma [28,29].